Announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience.

Alexza Pharmaceuticals licenses Staccato nicotine technology to Cypress Bioscience Alexza Pharmaceuticals, Inc http://sildenafilsa.com/suhagra-short-wiki-review.html . announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. . The Staccato system is a broad technology system and Alexza has even more Staccato-based product candidates than we can currently afford to build up on our very own. King, Alexza CEO and President. Related StoriesUF Health researcher reveals how betel nut's psychoactive chemical functions in the brainNew research shows that using e-cigarettes related to problematic drinkingNew evaluation points to usage of e-cigarettes as quitting aid among U.S.